Structured evidence table for Artichoke Leaf Blood Pressure Randomized Trial, generated from 1 reusable source document in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Artichoke Leaf Blood Pressure Randomized Trial | Low-density lipoprotein cholesterol (LDL-C) increases cardiovascular risk, whereas high-density lipoprotein cholesterol (HDL-C) decreases it []. | 4 | Vitulano Nicola (2025) | Effects of Novel Nutraceutical Combination on Lipid Pattern of Subjects with Sub-Optimal Blood Cholesterol Levels |
| Artichoke Leaf Blood Pressure Randomized Trial | Clinical evidence supports the effectiveness of lowering LDL-C to prevent cardiovascular events. | 4 | Vitulano Nicola (2025) | Effects of Novel Nutraceutical Combination on Lipid Pattern of Subjects with Sub-Optimal Blood Cholesterol Levels |
| Artichoke Leaf Blood Pressure Randomized Trial | Studies show that LDL-C is both a high-risk marker and a direct cause of cardiovascular disease []. | 4 | Vitulano Nicola (2025) | Effects of Novel Nutraceutical Combination on Lipid Pattern of Subjects with Sub-Optimal Blood Cholesterol Levels |
| Artichoke Leaf Blood Pressure Randomized Trial | 1 2 3 3 4 3 4 3 5 6 7 Cardiovascular diseases account for 32% of global deaths []. | 4 | Vitulano Nicola (2025) | Effects of Novel Nutraceutical Combination on Lipid Pattern of Subjects with Sub-Optimal Blood Cholesterol Levels |
Source documents